By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Mologen AG 

P.O. Box 332140

Berlin    D - 14180  Germany
Phone: 49-0-30-857-576-0 Fax: 49-0-30-857-576-50



Gene Therapy

Company News
Mologen AG (MOLGF.PK): First Combination Trial With MGN1703 And A Checkpoint Inhibitor In Collaboration With MD Anderson Cancer Center 1/19/2016 10:48:50 AM
Mologen AG (MOLGF.PK): Patient Enrollment Completed For Impulse Study With Immunotherapy Mgn1703 In Lung Cancer 10/30/2015 11:11:38 AM
Mologen AG (MOLGF.PK) To Present Poster At European Cancer Congress 2015 9/24/2015 9:58:45 AM
Mologen AG (MOLGF.PK): Recruitment For The TEACH Study With MGN1703 In HIV-Patients Completed 9/22/2015 9:22:45 AM
Mologen AG (MOLGF.PK) Is Presenting Two Posters At International Cancer Immunotherapy Conference 9/16/2015 9:40:40 AM
Mologen AG (MOLGF.PK): First Half Of 2015 Defined By Study Progress And Capital Increase 8/13/2015 9:04:52 AM
Mologen AG (MOLGF.PK): Oliver Krautscheid Reelected As Chairman Of The Supervisory Board 7/30/2015 12:25:16 PM
Dr. Mariola Söhngen Appointed As New CEO Of Mologen AG (MOLGF.PK) 7/23/2015 10:57:52 AM
Mologen AG (MOLGF.PK) Presented Poster At ESMO WCGI 2015 7/6/2015 11:47:13 AM
The Chairman Of The Supervisory Board Of Mologen AG (MOLGF.PK) Resigns From His Office As Board Member And Chairman And Is Nominated For Re-Election 6/18/2015 12:26:49 PM